HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 27.41
-2.22 (-7.49%)
At close: Jun 1, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 11.84 billion as of June 1, 2026. Its market cap has increased by 95.58% in one year.
Market Cap
11.84B
Enterprise Value
11.10B
Revenue
579.37M
Ranking
n/a
PE Ratio
95.47
Stock Price
27.41
Market Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 11.84B, a decrease of -37.26%. That is a compound annual growth rate of -7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 11.84B | 26.35% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 13.87B |
| Mabwell (Shanghai) Bioscience | 13.04B |
| Jinyu Bio-technology | 12.75B |
| Staidson (Beijing) BioPharmaceuticals | 12.32B |
| Pacific Shuanglin Bio-pharmacy | 12.26B |
| Tibet Cheezheng Tibetan Medicine | 11.93B |
| Inner Mongolia Furui Medical Science | 11.83B |
| Chengzhi | 11.64B |